How to read: Every bubble is one Indian tetracycline exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Tetracycline report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial tetracycline trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian tetracycline suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Tetracycline India trade report
P
Product scope
Tetracycline
All variants merged — branded and generic formulations of tetracycline
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
218
Every commercial tetracycline trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a mixed: Oct $246.2K, Nov $674.5K, Dec $355.2K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$246.2K
Oct USD
32 shipments
2
$674.5K
Nov USD
+174.0% MoM
3
$355.2K
Dec USD
-47.3% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 174.0% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $246K, making it the weakest month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: INDIANA OPHTHALMICS LLP maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import tetracycline from India, how much they buy, and who supplies each market
KEY TAKEAWAYDjibouti absorbs 34.5% of India’s 2025-Q4 tetracycline trade ($440.3K). Beyond the top 10 destinations, 48 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 19 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 48 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much tetracycline India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$197K
15.4% of trade
12 countries · 123 shipments
Europe
$372
0.0% of trade
5 countries · 12 shipments
Americas
$29K
2.3% of trade
11 countries · 20 shipments
Africa
$1.0M
82.3% of trade
19 countries · 59 shipments
Oceania
$100
0.0% of trade
3 countries · 4 shipments
Fig 4.1 Djibouti is the #1 corridor ($440K) — 30 flow arcs from India radiate across 5 continents.
How to read: The world map shows every country colored by how much Indian tetracycline it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
Djibouti
$440K
8
BRASSICA PHARMA PVT LTD
$440K
—
—
—
—
2
DR Congo
$253K
15
VIDACARE MEDICA PVT LTD
$168K
LABORATE PHARMACEUTICALS INDIA LTD
$76K
LEBEN LABORATORIES PVT LTD
$7K
3
Uganda
$134K
3
CENTAUR PHARMACEUTICALS PVT LTD
$106K
NEM LABORATORIES PVT LTD
$28K
—
—
4
Ethiopia
$96K
1
INDIANA OPHTHALMICS LLP
$96K
—
—
—
—
5
Uzbekistan
$59K
3
SWISS HEALTHCARE
$59K
—
—
—
—
6
Rwanda
$41K
1
INFUGEN PHARMA PVT LTD
$41K
—
—
—
—
7
Sri Lanka
$32K
2
GALENTIC PHARMA INDIA PVT LTD
$23K
CENTAUR PHARMACEUTICALS PVT LTD
$9K
—
—
8
Mozambique
$30K
4
BDH INDUSTRIES LTD
$30K
—
—
—
—
9
Tajikistan
$28K
2
EVOLET HEALTHCARE PVT LTD
$16K
GOGA HEALTHCARE
$11K
—
—
10
Afghanistan
$26K
6
SIEMEN LABORATORIES (INDIA)
$17K
ANCALIMA LIFESCIENCES LTD
$9K
VATS INDUSTRIES PVT LTD
$0
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 15.4% of USD — but Djibouti is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
34.5%
#1 country share
Djibouti alone
76.9%
Top 5 share
5 of 50 countries
95.5%
Top 15 share
Long tail of 35 countries = 4.5%
HHI 1813
Destination HHI
Moderately concentrated
50
Countries served
Global pharma reach from India
19
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
57 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYBRASSICA PHARMA PVT LTD ($444.5K, 34.8% share) and VIDACARE MEDICA PVT LTD ($168.0K) together control 48.0% of India’s 2025-Q4 tetracycline trade. The top 5 suppliers hold 71.6%. 57 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian tetracycline suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 BRASSICA PHARMA PVT LTD leads by $276K over VIDACARE MEDICA PVT LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: BALAXI PHARMACEUTICALS LTD is #15 by value but #5 by volume.
Fig 5.2 BRASSICA PHARMA PVT LTD also leads by shipment count (10) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: BALAXI PHARMACEUTICALS LTD moves from #5 by volume to #15 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 57 tetracycline suppliers split into strategic segments
KEY TAKEAWAY15 suppliers (25%) generate 92.6% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 BRASSICA PHARMA PVT LTD and VIDACARE MEDICA PVT LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 92.6% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
61 importers across 50 countries — who is buying Indian tetracycline and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 67.2% of total USD. 95% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian tetracycline. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 APPLICANT is the #1 importer at $220K (17.3%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian tetracycline prices vary by supplier, country and dosage form
KEY TAKEAWAYTetracycline prices span 32911× ($0.0026 → $84.13). The coefficient of variation is 3.23. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. VIDACARE MEDICA PVTSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. BRASSICA PHARMA PVTSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Oct 2025
NEM LABORATORIES…
Uganda
Ointment
165
$28K
$168.25
Specialty / small-batch
Oct 2025
SYNCOM FORMULATI…
Haiti
—
20
$3K
$160.66
Specialty / small-batch
Oct 2025
NEM LABORATORIES…
Uganda
Ointment
1
$84.13
$84.13
Specialty / small-batch
Nov 2025
ALLEVIARE LIFE S…
Brazil
Tablet
1
$48.11
$48.11
Specialty / small-batch
Nov 2025
ALLEVIARE LIFE S…
Brazil
Tablet
1
$48.11
$48.11
Specialty / small-batch
Nov 2025
ALLEVIARE LIFE S…
Brazil
Tablet
1
$47.70
$47.70
Specialty / small-batch
Nov 2025
BRASSICA PHARMA …
Djibouti
Eye Drops
820
$23K
$28.00
Specialty / small-batch
Nov 2025
BRASSICA PHARMA …
Djibouti
ophthalmic
820
$23K
$28.00
Specialty / small-batch
Nov 2025
BRASSICA PHARMA …
Djibouti
ophthalmic
4K
$109K
$26.54
Specialty / small-batch
Nov 2025
BRASSICA PHARMA …
Djibouti
ophthalmic
4K
$109K
$26.54
Specialty / small-batch
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
SCOTT EDIL PHARM…
Honduras
Capsule
200K
$375.85
$0.0019
Dec 2025
DERRIC WOOD
United Arab Emirates
Capsule
18
$0.046
$0.0026
Small sample / trial shipment
Dec 2025
DERRIC WOOD
United Arab Emirates
Capsule
3
$0.0077
$0.0026
Small sample / trial shipment
Dec 2025
DELIGHT HEALTHCARE
DR Congo
Ointment
200
$0.797
$0.0040
Small sample / trial shipment
Dec 2025
DERRIC WOOD
United Arab Emirates
Capsule
9
$0.043
$0.0048
Small sample / trial shipment
Dec 2025
DERRIC WOOD
United Arab Emirates
Capsule
3
$0.014
$0.0048
Small sample / trial shipment
Dec 2025
PREMIER ENTERPRISE
United Arab Emirates
Capsule
13
$0.062
$0.0048
Small sample / trial shipment
Dec 2025
DERRIC WOOD
United Arab Emirates
Capsule
27
$0.132
$0.0049
Small sample / trial shipment
Oct 2025
VIDACARE MEDICA …
DR Congo
Capsule
1.2M
$9K
$0.0074
Bulk volume discount
Oct 2025
VIDACARE MEDICA …
DR Congo
Capsule
1.5M
$11K
$0.0075
Bulk volume discount
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship tetracycline, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYTetracycline leaves India through 14+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), KANDLA SEA, PATLI ICD) handle 95.6% of total USD. SEA moves 23% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $950K — top 14 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYSEA dominates at 23% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$1.1M
83.3% of USD · 22.9% of ships
ICD
$140K
10.9% of USD · 4.6% of ships
AIR
$63K
4.9% of USD · 71.6% of ships
ROAD
$10K
0.8% of USD · 0.9% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → Africa ($856K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYDjibouti is the most concentrated destination (HHI 10000, 1 suppliers). Singapore is the most competitive (HHI 3134).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Djibouti (HHI 10,000) is the most concentrated — Singapore (HHI 3,134) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
APPLICANT
Djibouti
BRASSICA PHARMA …
$220K
4
HIGH
STE PRINCE PHARMA SARL
DR Congo
VIDACARE MEDICA …
$168K
9
HIGH
GITTOES PHARMACEUTIC…
Uganda
CENTAUR PHARMACE…
$106K
1
HIGH
ETHIOPIAN PHARMACEUT…
Ethiopia
INDIANA OPHTHALM…
$96K
1
MEDIUM
SMART PHARMO LLC
Uzbekistan
SWISS HEALTHCARE
$59K
3
MEDIUM
PROFARMA LDAAV.OLOF …
Mozambique
BDH INDUSTRIES LTD
$30K
4
MEDIUM
RENE PHARMACY LTD
Uganda
NEM LABORATORIES…
$28K
2
MEDIUM
STATE PHARMACEUTICAL…
Sri Lanka
GALENTIC PHARMA …
$23K
1
MEDIUM
Conclusion: 58 buyers depend on exactly one Indian supplier, representing $860K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
EMIRATES POST GROUP
United Arab Emirates
4
$28
FALCON TRANSGL…
MEDIUM
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
Djibouti
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
DR Congo
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Uganda
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Ethiopia
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Uzbekistan
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
Rwanda
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Sri Lanka
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Mozambique
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Tajikistan
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Afghanistan
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
Zambia
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
United Arab Emirates
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Turkmenistan
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Ghana
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Timor-Leste
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 11 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in Djibouti
This Q
HIGH
A2
Offer alternative to EMIRATES POST
This Q
HIGH
A3
Audit Djibouti lock-ins (HHI 10000)
This Q
MED
A5
Enter Uganda (2 suppliers)
This Q
HIGH
A6
Enter Djibouti (1 suppliers)
This Q
MED
A8
Build DR Congo distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
Uganda
Africa
2
$134K
+282.4%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
2
Djibouti
Africa
1
$440K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
3
Ethiopia
Africa
1
$96K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
4
Zambia
Africa
1
$26K
+217.9%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
5
Uzbekistan
Asia
1
$59K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
6
Rwanda
Africa
1
$41K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
7
Sri Lanka
Asia
2
$32K
-100%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
8
Mozambique
Africa
1
$30K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
9
Tajikistan
Asia
2
$28K
-100%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
10
Afghanistan
Asia
3
$26K
-43.4%
LOW
Low competition (3 suppliers), accessible market
11
Angola
Africa
3
$11K
+64.6%
LOW
Growing 65% with only 3 competitors
12
Turkmenistan
Asia
1
$13K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
13
Ghana
Africa
1
$12K
-99.1%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
14
Timor-Leste
Asia
1
$11K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
15
Nicaragua
Other
1
$10K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
This report covers 218 2025-Q4 Tetracycline shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/tetracycline
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 218 2025-Q4 tetracycline shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian tetracycline shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
218
across all regions
TOTAL USD
$1.28M
2025-Q4 FOB value
UNITS
36.3M
tablets, capsules, etc.
SUPPLIERS
57
Indian exporters
BUYERS
61
global importers
COUNTRIES
50
destinations
§10.2 Regional breakdown
Africa
$1.05M
82.3%
19 ctry · 59 ships
Asia
$197K
15.4%
12 ctry · 123 ships
Europe
$372.38
0.0%
5 ctry · 12 ships
Americas
$29K
2.3%
11 ctry · 20 ships
Oceania
$99.61
0.0%
3 ctry · 4 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $1.05M (82.3%), spanning 19 countries.
🏢
57 Indian suppliers shipped to 61 buyers across 50 countries — average shipment value $6K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 59 global tetracycline importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian tetracycline in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
APPLICANT
Djibouti
4
$220K
BRASSICA PHARMA PVT …
Eye Drops, Ointment, ophthalmic
2
STE PRINCE PHARMA SARL
DR Congo
9
$168K
VIDACARE MEDICA PVT …
Capsule
3
GITTOES PHARMACEUTICALS LTD
Uganda
1
$106K
CENTAUR PHARMACEUTIC…
Ointment
4
ETHIOPIAN PHARMACEUTICALS SUPPLY SE
Ethiopia
1
$96K
INDIANA OPHTHALMICS …
Ointment
5
SMART PHARMO LLC
Uzbekistan
3
$59K
SWISS HEALTHCARE
Capsule, Ointment
6
PROFARMA LDAAV.OLOF PALM N
Mozambique
4
$30K
BDH INDUSTRIES LTD
Ointment
7
RENE PHARMACY LTD
Uganda
2
$28K
NEM LABORATORIES PVT…
Ointment
8
STATE PHARMACEUTICALS CORP
Sri Lanka
1
$23K
GALENTIC PHARMA INDI…
Ointment
9
ESVEE MEDICARE LTD
Zambia
1
$20K
AFRICURE PHARMACEUTI…
Capsule
10
ROSHAN BROTHERAN LTD
Afghanistan
2
$17K
SIEMEN LABORATORIES …
eye_ointment, Ointment
11
DUSTI PHARM LLC
Tajikistan
1
$16K
EVOLET HEALTHCARE PV…
Ointment
12
SAGLYK E.S.1958 (ANDALYP) STREET
Turkmenistan
1
$13K
INDIANA OPHTHALMICS …
Ointment
13
SHAMS NOORI PHARMA TRADING COMPANY
Afghanistan
1
$9K
ANCALIMA LIFESCIENCE…
Ointment
14
FARMANURA PVT LTD
Nepal
1
$8K
BLUE CROSS LABORATOR…
Drops
15
TRADEMAX COMERCIO GERAL (SU),LDA
Angola
1
$7K
ZENKO LIFE SCIENCE LLP
Tablet
16
MEDLINK PHARMACEUTICALS LTD
DR Congo
2
$7K
LEBEN LABORATORIES P…
Capsule
17
BALAXI HEALTHCARE DOMINICANA SRL
Dominican Republic
1
$7K
BALAXI PHARMACEUTICA…
Capsule
18
AUGUSTA LTD
Zambia
1
$6K
AFRICURE PHARMACEUTI…
Capsule
19
BALAXI HEALTHCARE GUATEMALA, S.A
Guatemala
2
$6K
BALAXI PHARMACEUTICA…
Capsule
20
REVOMED IMPORT & EXPORT
Sudan
2
$4K
BRASSICA PHARMA PVT …
Ointment
21
KMT PHARMACEUTICAL & MEDICAL SUPPLI
Bhutan
1
$2K
UNIM PHARMALAB LTD
water soluble
22
NEW GPC INCQUEENS ATLANTIC INDUSTRI
Guyana
1
$2K
H V A INTERNATIONAL
Capsule
23
SVPP SARL
Senegal
1
$2K
SIXER TRADING PVT LTD
Ointment
24
FDECAME
DR Congo
1
$1K
SIDHAANT LIFE SCIENC…
Eye Drops
25
PRINCE PHARMA
DR Congo
1
$873.22
FLOURISH PHARMA
Capsule
26
APERA NV
Suriname
2
$681.96
UNI MED INDIA
Ointment
27
EMIRATES POST COMPANY
United Arab Emirates
65
$613.90
DERRIC WOOD
Capsule, Ointment, Tablet
28
QUEEENS ENTERPRISES CO LTD
Sudan
1
$239.59
BAKER & DAVIS PVT LTD
eye_ear_drops
29
ZAPATERO INTERNATIONAL LTD
Mauritius
4
$217.06
PLEASANT EXPORTS
Capsule, Tablet
30
JORDAN HASHEMITE CHARITY ORGANIZATI
Jordan
2
$107.07
LOB INTERNATIONAL
Ointment
31
TO THE CONSIGNEE TO THE ORDER OF
Australia
1
$73.63
ZYPHARS PHARMACEUTIC…
32
REPUBLIQUE ISLAMIQUE DE MAURITANIE
Mauritania
2
$65.17
AUROLAB FOUNDATION
Ointment
33
ALSTERN MARINE & OFFSHORE PTE LTD
Singapore
1
$53.04
PROGENE PHARMA PVT LTD
Capsule
34
SAVIO LUCAS XAVIER DA SILVA
Brazil
1
$48.11
ALLEVIARE LIFE SCIEN…
Tablet
35
GUILHERME ROSA DO AMARAL
Brazil
1
$47.70
ALLEVIARE LIFE SCIEN…
Tablet
36
SUCCESS INTER LINK PTE LTD
Singapore
1
$40.84
SANITAS MEDTECH INST…
Capsule
37
MINISTERY OF HEALTH OF MOROCCO
Morocco
1
$34.76
LOB INTERNATIONAL
Ointment
38
PRESIDENT OF THE HIGHER ISLAMIC
Republic of the Congo
1
$33.73
AUROLAB FOUNDATION
Ointment
39
CROISSANT ROUGE ALGERIEN CRA
Algeria
1
$32.02
AUROLAB FOUNDATION
Ointment
40
FONDATION BONNE ACTION
Burundi
1
$31.72
AUROLAB FOUNDATION
Ointment
41
EMIRATES POST GROUP
United Arab Emirates
11
$27.50
FALCON TRANSGLOBAL
Capsule, Tablet
42
THE MASTER OF X PRESS MOY
Panama
2
$14.95
3CUBE MEDICARE PVT LTD
eye ointment
43
THE MASTER OF CRYSTAL A
Panama
2
$14.29
3CUBE MEDICARE PVT LTD
Ointment
44
THE MASTER OF LOS ANGELES SPIRIT
Germany
2
$13.79
3CUBE MEDICARE PVT LTD
Ointment
45
THE MASTER OF GH CHRISTIE SHIP SPA
South Korea
3
$13.73
3CUBE MEDICARE PVT LTD
Ointment, Capsule
46
THE MASTER OF GH ANGELOU SHIP SPA
South Korea
4
$13.63
3CUBE MEDICARE PVT LTD
Capsule, Ointment
47
THE MASTER OF SKOMER ISLAND
Singapore
3
$11.56
3CUBE MEDICARE PVT LTD
Capsule, Ointment
48
THE MASTER OF CHALLENGE POLLUX SHIP
Singapore
1
$10.82
3CUBE MEDICARE PVT LTD
Ointment
49
THE MASTER OF EA NODDY
Netherlands
1
$9.83
3CUBE MEDICARE PVT LTD
Ointment
50
THE MASTER OF MEDITERRANEAN EXPRES
Belgium
1
$8.78
3CUBE MEDICARE PVT LTD
Ointment
51
NEW SIGHT LTD
Republic of the Congo
1
$7.78
AUROLAB FOUNDATION
Ointment
52
THE MASTER OF SEAWAYS MUSE SHIP SPA
Netherlands
1
$7.31
3CUBE MEDICARE PVT LTD
Ointment
53
THE MASTER OF PLATA LUCKY
United States
1
$6.92
3CUBE MEDICARE PVT LTD
Ointment
54
THE MASTER OF GAS XANADU
Netherlands
1
$5.68
3CUBE MEDICARE PVT LTD
Ointment
55
THE MASTER OF SEAWAYS MIRAGE SHIP
United States
1
$5.50
3CUBE MEDICARE PVT LTD
Ointment
56
THE MASTER OF X PRESS GODAVARI
Netherlands
1
$5.06
3CUBE MEDICARE PVT LTD
Ointment
57
THE MASTER OF SHELTER ISLAND
Netherlands
1
$2.05
3CUBE MEDICARE PVT LTD
Capsule
58
HARLEYS LTD
Kenya
1
$0.0000
AJANTA PHARMA LTD
Ointment
59
TRUST ANESTHETIC LTD
Afghanistan
3
$0.0000
VATS INDUSTRIES PVT …
Capsule
This report covers 218 2025-Q4 Tetracycline shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/tetracycline
Talk to our trade analyst
Need a custom tetracycline report or a deeper dive into any market? Our team is ready.